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To visualize mitochondrial morphology, we will subretinally inject AAV2/6-CD68-mito-Dendra2 in rd10 mice, or 
use a mitochondria-labeled mouse model for ONC. Changes in mitochondrial volume based on image rendering 
will identify connected or fragmented mitochondrial networks. 
In both degenerative models, we observed reactive microglia based on increased Sholl intersections closer to 
the cell soma and an increased percentage of CD68 volume within microglia when compared to control. 
Importantly, this activation was found only in the synaptic layer with closest proximity to the degenerating 
neurons, while the furthest microglia were less reactive. Interestingly, we observed that microglia’s average 
mitochondrial volume was significantly reduced not only in the expected synaptic layer proximal to neuronal 
degeneration for each model, but in both synaptic layers. The reduction in the average mitochondrial volume per 
microglia indicates a more fragmented mitochondrial network. Since the microglia furthest from degenerating 
neurons remain less active, but show mitochondrial fragmentation, we predict that this could be an intermediate 
phase of the microglia transition. Together, these data suggest that mitochondria morphology may be an early 
indicator for the microglia reactive state and a potential target for microglia modulation. 
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Amyloid-beta (Abeta) peptide deposits and hyperphosphorylated tau protein (phospho-tau) accumulate in 
Alzheimer’s disease (AD) brains. These abnormal protein aggregates leads to glial activation, synaptic 
dysfunction, neuronal loss and cognitive decline. While microglial response has mostly been analyzed in relation 
to Abeta accumulation, little is still known about inflammatory processes associated with tau pathology. 
Microglial reactivity and defective glial responses have been involved in these proteinopathies. Our aim is to 
clarify the effects of Abeta and tau separately, in order to improve the comprehension of their differential 
contribution to neuroinflammation and neurodegeneration. We compared the progression of these processes in 
an amyloidogenic AD model (APPSL/PS1M146L) and two different models of tauopathy (ThyTau22 and 
hP301S) from 2 to 18 months of age.  Accumulation of aggregated proteins was assessed using specific anti-
Abeta and phospho-tau antibodies. Inflammatory response was studied using a battery of microglial markers 
(Iba1, CD45, CD68, Trem2 and Gal-3). In the hippocampus of these models, Tau and Abeta pathologies initiated 
as early as 2 months of age and increased progressively with aging. Neuritic plaques induced a strong microglial 
activation associated to plaques in APP/PS1 mice. Interestingly, inflammatory markers and microglial reactivity 
were barely increased in the hippocampus of ThyTau mice in contrast to not only APP/PS1, but also to P301S 
mice, which displayed a prominent microglial response. Deciphering the specific effects of Abeta, tau and their 
different toxic species, would indeed enable the development of novel therapeutic strategies and drugs targeting 
neuroinflammatory pathways related to these proteinopathies. 
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